Potential Compounds as Inhibitors of Staphylococcal Virulence Factors Involved in the Development of Thrombosis

For many years, staphylococci have been detected mainly in infections of the skin and soft tissues, organs, bone inflammations, and generalized infections. Thromboembolic diseases have also become a serious plague of our times, which, as it turns out, are closely related to the toxic effects of stap...

Full description

Saved in:
Bibliographic Details
Main Authors: Anna Lichota, Krzysztof Gwozdzinski, Monika Sienkiewicz
Format: Article
Language:English
Published: MDPI AG 2025-07-01
Series:Toxins
Subjects:
Online Access:https://www.mdpi.com/2072-6651/17/7/340
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849252016927277056
author Anna Lichota
Krzysztof Gwozdzinski
Monika Sienkiewicz
author_facet Anna Lichota
Krzysztof Gwozdzinski
Monika Sienkiewicz
author_sort Anna Lichota
collection DOAJ
description For many years, staphylococci have been detected mainly in infections of the skin and soft tissues, organs, bone inflammations, and generalized infections. Thromboembolic diseases have also become a serious plague of our times, which, as it turns out, are closely related to the toxic effects of staphylococci. <i>Staphylococcus aureus,</i> because of the presence of many different kinds of virulence factors, is capable of manipulating the host’s innate and adaptive immune responses. These include toxins and cofactors that activate host zymogens and exoenzymes, as well as superantigens, which are highly inflammatory and cause leukocyte death. Coagulases and staphylokinases can control the host’s coagulation system. Nucleases and proteases inactivate various immune defense and surveillance proteins, including complement components, peptides and antibacterial proteins, and surface receptors that are important for leukocyte chemotaxis. On the other hand, secreted toxins and exoenzymes are proteins that disrupt the endothelial and epithelial barrier as a result of cell lysis and disintegration of linking proteins, which ultimately increases the risk of thromboembolism. In this review, we discuss various virulence factors and substances that may inhibit their activity.
format Article
id doaj-art-adb95d172f374927b4dd972837b2b46a
institution Kabale University
issn 2072-6651
language English
publishDate 2025-07-01
publisher MDPI AG
record_format Article
series Toxins
spelling doaj-art-adb95d172f374927b4dd972837b2b46a2025-08-20T03:56:45ZengMDPI AGToxins2072-66512025-07-0117734010.3390/toxins17070340Potential Compounds as Inhibitors of Staphylococcal Virulence Factors Involved in the Development of ThrombosisAnna Lichota0Krzysztof Gwozdzinski1Monika Sienkiewicz2Department of Pharmaceutical Microbiology and Microbiological Diagnostics, Medical University of Lodz, 90-151 Lodz, PolandDepartment of Oncobiology and Epigenetics, University of Lodz, 90-236 Lodz, PolandDepartment of Pharmaceutical Microbiology and Microbiological Diagnostics, Medical University of Lodz, 90-151 Lodz, PolandFor many years, staphylococci have been detected mainly in infections of the skin and soft tissues, organs, bone inflammations, and generalized infections. Thromboembolic diseases have also become a serious plague of our times, which, as it turns out, are closely related to the toxic effects of staphylococci. <i>Staphylococcus aureus,</i> because of the presence of many different kinds of virulence factors, is capable of manipulating the host’s innate and adaptive immune responses. These include toxins and cofactors that activate host zymogens and exoenzymes, as well as superantigens, which are highly inflammatory and cause leukocyte death. Coagulases and staphylokinases can control the host’s coagulation system. Nucleases and proteases inactivate various immune defense and surveillance proteins, including complement components, peptides and antibacterial proteins, and surface receptors that are important for leukocyte chemotaxis. On the other hand, secreted toxins and exoenzymes are proteins that disrupt the endothelial and epithelial barrier as a result of cell lysis and disintegration of linking proteins, which ultimately increases the risk of thromboembolism. In this review, we discuss various virulence factors and substances that may inhibit their activity.https://www.mdpi.com/2072-6651/17/7/340staphylococcal virulence factorstherapeutic strategiesstaphylococcal infectionsthrombosis
spellingShingle Anna Lichota
Krzysztof Gwozdzinski
Monika Sienkiewicz
Potential Compounds as Inhibitors of Staphylococcal Virulence Factors Involved in the Development of Thrombosis
Toxins
staphylococcal virulence factors
therapeutic strategies
staphylococcal infections
thrombosis
title Potential Compounds as Inhibitors of Staphylococcal Virulence Factors Involved in the Development of Thrombosis
title_full Potential Compounds as Inhibitors of Staphylococcal Virulence Factors Involved in the Development of Thrombosis
title_fullStr Potential Compounds as Inhibitors of Staphylococcal Virulence Factors Involved in the Development of Thrombosis
title_full_unstemmed Potential Compounds as Inhibitors of Staphylococcal Virulence Factors Involved in the Development of Thrombosis
title_short Potential Compounds as Inhibitors of Staphylococcal Virulence Factors Involved in the Development of Thrombosis
title_sort potential compounds as inhibitors of staphylococcal virulence factors involved in the development of thrombosis
topic staphylococcal virulence factors
therapeutic strategies
staphylococcal infections
thrombosis
url https://www.mdpi.com/2072-6651/17/7/340
work_keys_str_mv AT annalichota potentialcompoundsasinhibitorsofstaphylococcalvirulencefactorsinvolvedinthedevelopmentofthrombosis
AT krzysztofgwozdzinski potentialcompoundsasinhibitorsofstaphylococcalvirulencefactorsinvolvedinthedevelopmentofthrombosis
AT monikasienkiewicz potentialcompoundsasinhibitorsofstaphylococcalvirulencefactorsinvolvedinthedevelopmentofthrombosis